Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto – Presentation of Q3 quarterly results 2023

By HC Andersen Capital
BioPorto

Meet and ask questions to BioPorto CEO Tony Paré and VP of Finance George Rosa on 1 November at 2.00 PM CET when they present the financial results for the first nine months of 2023 along with the latest development of the NGAL-test.

Disclaimer: HC Andersen Capital receives payment from BioPorto for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 18 October 09.46 AM.

Recent videos

Hanza, Audiocast, Q4'25
24.02.2026 klo 11.00 HANZA
Bonesupport, Audiocast, Year end report, 2025
24.02.2026 klo 11.00 Bonesupport
Harvia Q4’25: Hot expectations
24.02.2026 klo 10.48 Harvia
Intellego Technologies, Audiocast, Q4'25
20.02.2026 klo 16.00 Intellego Technologies
Cantargia, Audiocast, Q4'25
20.02.2026 klo 16.00 Cantargia
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.